Merck Pulls EPS Guidance To Avoid "Indiscriminate Short-Term Cost Cutting"
This article was originally published in The Pink Sheet Daily
Executive Summary
In Kenneth Frazier's first financial call as CEO, the exec withdrew Merck's long-term earnings guidance, citing healthcare reform costs, European pricing pressure and a late-stage pipeline setback.